Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2209 ARTÍCULOS , VIENDO DEL 1 AL 15

Dysregulated metal homeostasis in Alzheimer's disease: From pathological modulators to therapeutic targets

Yang J, Lou F, Sun W, Li M, Su L, Wang Y, Li P, Su J.

Pharmacol Res. 2026 Nov;233:109690. doi: 10.1016/j.phrs.2026.109690. Epub 2026 Oct 17.

Plasma Angiotensin-Converting Enzyme as a Prioritized Candidate Target for Alzheimer's Disease: Evidence From Proteome-Wide Mendelian Randomization and a Large Prospective Cohort Study

Huang P, Tang H, Feng Z, Stergiakouli E, Gaunt TR, Zheng J, Lu Y.

J Am Heart Assoc. 2026 Nov 3;15(21):e038766. doi: 10.1161/JAHA.124.038766. Epub 2026 Oct 23.

Rapidly Progressive Alzheimer's Disease: Candidate Mechanisms and Diagnostic Challenges

Cao M, Leng L, Liu P, Fan Z, Peng G.

Clin Interv Aging. 2026 Oct 26;21:638910. doi: 10.2147/CIA.S638910. eCollection 2026.

The Role of the Glymphatic System in Alzheimer's Disease: Mechanisms, Evidence, and Therapeutic Implications

Li Y, Li J, Liu X, Wang T, Ma L, She R, Chang Y.

Rejuvenation Res. 2026 Oct;29(5):225-234. doi: 10.1177/15491684261442832. Epub 2026 Apr 14.

ADAM10 and its role in Alzheimer disease

Agüero P, Gómez Tortosa E.

Neurologia (Engl Ed). 2026 Oct;41(8):502083. doi: 10.1016/j.nrleng.2026.502083. Epub 2026 May 5.

Efficacy and safety of donanemab in the European eligible population: TRAILBLAZER-ALZ 2 post-hoc analyses

Jessen F, Dell'Agnello G, Zimmer JA, Sapin C, Dichter S, Doty E, Epelbaum S, Evans CD, Hauck PM, Khanna R, Brooks DA, Sims JR, Agosta F; Alzheimer’s Disease Neuroimaging Initiative (ADNI).

J Prev Alzheimers Dis. 2026 Oct;13(8):100605. doi: 10.1016/j.tjpad.2026.100605. Epub 2026 May 27.

Appropriate use recommendations of the Spanish Society of Neurology's Behavioural Neurology and Dementia Study Group on anti-amyloid antibodies in the treatment of Alzheimer disease

Sánchez-Valle R, Alcolea D, Amer Ferrer G, Balasa M, Casado Naranjo I, Fortea J, Lladó A, Lleó A, Montes AM, Martinez Lozano L, Martínez-Lage P, Matias-Guiu JA, Mendioroz M, Perez Martinez DA, Ripoll GP, Riverol M, Sanchez-Juan P, Bondía HV; Spanish Society of Neurology’s Behavioural Neurology, Dementia Study Group working group for the appropriate use of anti-amyloid monoclonal antibody treatment.

Neurologia (Engl Ed). 2026 Oct;41(8):502075. doi: 10.1016/j.nrleng.2026.502075. Epub 2026 May 26.

Aquaporin‑4 polarization and glymphatic function in Alzheimer's disease: Mechanisms, modulators, and therapeutic strategies

Huang B, Tang G.

Pathol Res Pract. 2026 Oct;286:156564. doi: 10.1016/j.prp.2026.156564. Epub 2026 May 26.

Unveiling the pathogenesis and therapeutic strategies of Alzheimer's disease through cuproptosis

Xu S, Mu J, Wang Z, Yang J, Tian D, Shi T, Lan J, He P, Hao Z, Fu Y, Xing L, Ye J, Wang J.

Biometals. 2026 Oct;39(5):1361-1384. doi: 10.1007/s10534-026-00835-5. Epub 2026 Jun 18.

Clonal hematopoiesis in Alzheimer's brain: Protective, pathogenic, and context-dependent?

Zhao H, King KY, Wong ST.

Trends Mol Med. 2026 Oct;32(10):963-965. doi: 10.1016/j.molmed.2026.06.009. Epub 2026 Jul 2.

Tau-ing and fro-ing: the tanycytic shuttle in neurodegeneration

Prévot V, Schwaninger M, Nogueiras R, Rasika S.

J Prev Alzheimers Dis. 2026 Oct;13(8):100643. doi: 10.1016/j.tjpad.2026.100643. Epub 2026 Jul 4.

The multifaceted roles of IL-1β in Alzheimer's disease: From pathogenic amplifier to neuroimmune modulator

Pilat D, Baranger K, Rivera S.

Cytokine Growth Factor Rev. 2026 Oct;91:82-98. doi: 10.1016/j.cytogfr.2026.07.004. Epub 2026 Jul 17.

Regulation of different kinases for Alzheimer's disease therapy: progresses and perspectives

Han M, Liao Q, He S, Guo L, Lu Z, Wang X, Sun W, Duan Y, Lyu W, Li Q.

Bioorg Chem. 2026 Oct 5;181:110300. doi: 10.1016/j.bioorg.2026.110300. Epub 2026 Jul 25.

Pharmacological targeting of neuroimmune-synaptic interactions in Alzheimer's disease: Integrating NETosis, microglia, and synaptic vulnerability

Juanlu C, Chen LH.

Curr Opin Pharmacol. 2026 Oct;90:102650. doi: 10.1016/j.coph.2026.102650. Epub 2026 Jul 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias